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1I. Introduction
The first exact description of trigeminal neuralgia (TN) is originated from John Locke 
in 1677 (16). The term tic douloureux was given by Nicholas André in 1756 (16) 
unequivocally referring to the spasms of the face caused by the intolerable pain. In 1773, John 
Fothergill (29) described 16 cases of periodic, shock-like facial pain. Since then, the periodic 
painful attacks of the face have become known as the syndrome of TN.
1.1. The clinical features of trigeminal neuralgia
TN is a condition characterized by electric shock-like, excruciating paroxysms of pain 
in the distribution of the trigeminal nerve, most often in the maxillary and mandibular nerves. 
The pain during any single episode is always unilateral and seldom lasts for more than a few 
seconds or a minute. It may be so intense that the patient winces; hence the term "tic". The 
paroxysms can recur frequently, sometimes several times a day. The interval between the 
pains becomes shorter and shorter, indicating the progressive nature of the disease. Another 
characteristic feature is the initiation of pain by obvious stimuli applied to certain areas on the 
face, lips or tongue, the "trigger zones", or by movements of these parts. The triggering 
stimulus is a tactile rather than a noxious one. During a paroxysm, the face may be fixed by a 
contortion or immobilized in a blank expression until the attack passes. Flushing of the 
affected side of the face and watering of the eye are usual. The attack usually stops abruptly, 
but may linger with diminishing severity and is followed by a refractory period of up to 2 or 3 
minutes. Usually, the patient chooses at all costs to avoid any form of physical stimulation of 
the face, but a few patients obtain amelioration by applying very firm pressure or rubbing the 
affected part.
1.2. Epidemiology of trigeminal neuralgia
TN is an uncommon cause of facial pain, occurring with a mean annual incidence of 4 
cases per 100 000 population (84). However, the incidence of TN increases with age, making 
it the most frequently occurring of the cephalic neuralgias in the population over 50 years of 
age (59). Although this disorder predominantly affects the older age group, individuals in 
their second or third decades of life can be affected. There is a slight predominance of females 
to males; 5.9 and 3.4 per 100 000 population, respectively (40). The right side of the face is 
slightly more frequently affected than the left, and rarely bilateral TN can occur.
21.3. Pathomechanism of trigeminal neuralgia
1.3.1. Nomenclature
In many cases of TN, well-circumscribed pathological conditions can be revealed in 
the background by imaging (CT and MRI). In these cases, the condition is called 
symptomatic TN. The pathological process may affect the sensory center and pathways of 
the trigeminal nerve in the brainstem. In these cases, the origin is central. The effects of 
pressure, tension, distortion, some kind of lesion by a tumor, vascular malformation, 
aneurysm, inflammation, developmental disorder and trauma of the skullbase, etc. on the 
peripheral structures of the trigeminal nerve (Gasserian ganglion and nerve roots) cause TN of 
peripheral origin. If no other cause than vascular compression of the trigeminal nerve can be 
identified, the TN is called classical (idiopathic or genuine).
Table 1
Causes of trigeminal neuralgia
Symptomatic Classical
Peripheral
tumor, vascular malformation, 
developmental disorder of the skullbase, 
trauma, inflammation
vascular compression
Central
multiple sclerosis, other demyelination, 
tumor, cavernoma, etc.
functional disturbance of 
trigeminal sensory nuclei in the 
brainstem
1.3.2. Peripheral causes
The arguments for a peripheral extrinsic origin include pathological features often 
seen at the level of the posterior root and occasionally at the level of the Gasserian ganglion. 
Compression, distortion or stretching of the trigeminal nerve by a normal or aberrant vessel, 
aneurysm, arteriovenous malformation, a slow-growing tumor, dural thickening, etc., most 
often in the posterior and less frequently in the middle cranial fossa, can cause TN. Irritation 
of trigeminal terminals by chronic oral and dental disease may also be the cause of tic 
douloureux.
3I. 3. 2. 1. Histological examinations aiming at the pathomechanism of trigeminal 
neuralgia
In the 1960-s, when excision of the Gasserian ganglion was an accepted surgical 
method for the treatment of TN, samples were taken from the Gasserian ganglion and the near 
sensory nerve roots (12, 41). Electron microscopic studies of the specimens have shown a 
pathology characterized by vacuolated ganglion cells, degenerative hypermyelination, and 
segmental demyelination with denudation of the axons (41).
During 12 microvascular decompressions (MVD) biopsies were taken from the 
trigeminal nerves at the site of neurovascular compression (NC) and the samples were 
investigated electron microscopically (24). A strong correlation could be found between the 
NC and the histological changes. In the cases of the most severe NC, there were areas where 
only a few axons remained and all of them were demyelinated. In this demyelinated areas the 
surviving nude axons were in bundles in close membrane-to-membrane contact. There was 
also evidence for attempted remyelination and for aberrant remyelination where several axons 
were being bound together in the same myelin sheath (20). Adjacent areas contained more 
surviving axons, including a significant proportion having a residual myelin sheath, albeit 
disrupted. In many biopsy samples, there was an overproduction of collagen in the 
extracellular matrix. In all cases, the degenerative changes were most severe at the site of NC, 
and distant from this site, in either cross-section or longitudinal section, they became less (24, 
36).
I. 3. 2. 2. The pathophysiology of pain paroxysm in trigeminal neuralgia: the 
ignition theory (69)
Sensory neurons frequently become electrically hyperexcitable when injured and a 
source of an abnormal spike discharge (17, 25, 44, 83, 87). In cases of TN, such ectopic 
pacemaker activity could arise from the following:
1. dys- or demyelinated root axons;
2. swollen endbulbs and sprouts at the end of severed axons; and
3. axotomized cell somata within the trigeminal ganglion.
When ectopic firing occurs spontaneously, it gives rise to background paresthesias and 
burning sensations. Other injured sensory neurons are silent, but have a hair-trigger threshold 
such that momentary stimulation induces a burst of spontaneous firing lasting for seconds or 
even minutes. This triggered activity or neuronal afterdischarge, is considered to be the 
background of the ignition hypothesis i.e. the cause of the pain paroxysms (neuralgiform 
4pain) associated with TN (7, 25, 53). Although the afterdischarge is set off by an external 
stimulus, the spiking itself is self-sustaining, a reflection of the intrinsic repetitive firing 
tendency of injured afferent neurons (7, 8, 25). Afterdischarge bursts may also occur without 
any obvious trigger stimulus (24).
The intense paroxysms of pain and their sudden onset indicate that something 
synchronizes the afterdischarge burst in large numbers of trigeminal ganglion neurons. The 
ignition hypothesis proposes that synchronization of the afterdischarge is a result of neuron- 
to-neuron crossexcitation at the site of root compression or in the trigeminal ganglion (69). 
Two processes contribute to the synchronization:
1. Groups of axons without myelin sheaths, in close apposition to one another without 
an intervening glial process, is a pathological condition known to facilitate axon-to-axon 
crossexcitation named ephaptic crosstalk (3, 28, 54, 70, 74). Thus, the actual stimulation of a 
facial or intraoral trigger point innervated by one or more members of such a coupled group 
might activate the entire group, resulting in a pain paroxysm.
2. The other synchronization mechanism, crossed afterdischarge, is even more 
important for TN paroxysms because it affects a much larger proportion of afferent neurons. 
It occurs both within sensory ganglia and at sites of nerve injury. Specifically, impulse 
activity evokes nonsynaptic release of a neurotransmitter and/or K+ into the interstitial space. 
These mediators move by diffusion and excite intrinsic burst activity (afterdischarge) in 
neighboring neurons (4, 5, 26, 53, 80). In this case, a short stimulus at a peripheral trigger 
point could be enough to evoke a massive synchronous afterdischarge (69).
According to the ignition hypothesis, the effects of both synchronizing mechanisms 
may be increased by positive feedback, i.e., each new neuron involved following the initial 
trigger stimulus tends to involve activity in additional neighboring neurons. These, in turn, 
elicit activity in still more neurons. The resulting chain reaction is felt as a paroxysmal 
explosion, the characteristic lightning attack of TN (69). Crossed afterdischarge is 
preferentially triggered by activity in A0 afferents, those that are activated by light touch (5). 
Correspondingly, pain paroxysms in TN are typically triggered by light touch stimuli and not 
by pinch.
The characteristics of pain paroxysm in TN are claimed to have an electric shock-like 
quality. Everyday electrical shocks evoke around 50 Hz activity in all types of afferents 
simultaneously, which gives rise to the shock-like sensation. Paroxysms of ectopic 
afterdischarge, amplified and synchronized by ephaptic crosstalk and crossed afterdischarge, 
are expected to evoke this pattern of activity (24).
5The self-sustaining afterdischarge in sensory neurons usually persists for a few tens of 
seconds. The mechanism that stops the burst is hyperpolarization due to a K+ conductance 
activated by Ca“ entry during the burst (6). The hyperpolarization may last for several 
minutes and also render the cell less responsive than normal to subsequent trigger stimuli. 
This can be the explanation of the refractory period that occurs in TN when, following an 
attack, another attack can not be triggered for 2-3 minutes (49).
1.3.3. Central mechanism
Pathological functions of the sensory nuclei in the brainstem and spinal cord of the 
trigeminal nerve can be suspected in those cases where no anatomical lesion can be identified 
with sensitive imaging methods. The several ideas of central mechanisms are based on 
complicated neurophysiological and neurohormonal processes which are theoretical at present 
(14, 43, 42, 63). A central mechanism can be considered in cases of multiple sclerosis where 
demyelinated foci can be proved in the brainstem via MRI.
1.4. The clinical management of trigeminal neuralgia
1.4.1. Medical treatment
Medical treatment is considered to be the first choice in patients with TN. 
Carbamazepine, phenytoin, Baclofen, clonazepam, gabapentin or a combination of these 
agents are the first line of treatment. Carbamazepine, which has proved to be the most 
beneficial remedy in TN, is effective in more than 80% of the patients initially, but 25% later 
become refractory to the treatment (71). If medical treatment fails to relieve the pain or if 
side-effects force discontinuation of the treatment, surgery deserves consideration.
I. 4. 2. Surgical treatment
I. 4. 2. 1. For many years, TN was treated with various kinds of ablative methods 
(injections along the trigeminal pathways, trigeminal branch avulsion, subtemporal and 
suboccipital retrogasserian neurotomy, trigeminal tractotomy); many of them had severe side­
effects (keratitis, analgesia dolorosa) and impaired the nerve functions and they are no longer 
recommended. There are still ablative methods, such as the controlled thermocoagulation of 
the Gasserian ganglion and rootlets, the glycerol rhizotomy and balloon compression of the 
Gasserian ganglion which are widely used with moderate side effects. Recently the 
stereotactic irradiation of the entry zone of the trigeminal nerve has been also used. In contrast 
6with these ablative methods, which provide treatment of the symptoms, MVD is a nonablative 
surgical method in which the normal anatomy is restored.
I. 4.2.2. History of microvascular decompression
In 1934, Walter Dandy (22) published his observation during lateral suboccipital 
exposures for TN that vascular compression of the trigeminal root is a major cause of TN. In 
1959, Gardner & Miklos (33) first reported the treatment of TN by a neurovascular 
decompression procedure. The first MVD was performed in 1966 (68). Jannetta then began a 
systematic microsurgical study of trigeminal neurovascular relationships, which was 
published in 1967 (37), together with his hypothesis that NC may cause the focal 
demyelination of trigeminal sensory root axons, and thereby ephaptic short circuits that were 
responsible for the neuralgia. Over the subsequent 35 years, the work of Jannetta (37, 38, 39) 
and other neurosurgeons led to this procedure becoming an accepted mode of treatment for 
TN.
In Hungary, the first MVD was accomplished by Merei with the active assistance of 
Jannetta in 1973. From that time on up to 1989, only a few MVDs were performed in the 
country, until our team started to use this method regularly to treat TN (50, 51).
1.4.2.3. Surgical anatomy
NC of the trigeminal nerve may be caused by arteries, veins and rarely by thick 
arachnoid bundles. Most frequently, the superior cerebellar artery is the compressing vessel as 
it normally courses near the entry zone of the trigeminal nerve; however, any elongated, 
tortuous artery may create a loop affecting the nerve (Figure 1/A). The veins also display 
great variations in this region. The most frequent compressing vein is the lateral (transverse) 
pontine vein (58) (Figure 1/B).
7Figure 1
The possible arteries (A) and veins (B) causing compression of the trigeminal nerve
BA: basilar artery, VA: vertebral artery, AICA: anterior inferior cerebellar artery, PICA: posterior inferior 
cerebellar artery, n.V.: trigeminal nerve
LMV- lateral mesencephalic vein, SPV: superior petrosal vein, ACV: anterior cerebellar vein, LPV: lateral 
pontine vein, n.V.: trigeminal nerve
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8Typical site of NC is at the entry zone of the trigeminal nerve to the pons. The 
significance of this fact is that the nerve root near the brainstem is a central nervous system 
segment containing an oligodendroglial myelin sheet, while the distal part of the nerve 
contains a Schwann cell-produced myelin sheet. The former is very sensitive, while the 
peripheral part is more resistant to compression (72) (Figure 2).
Figure 2
Sketch of the entry zone of the trigeminal nerve.
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9II. Aims of the study
1. Primarily, to learn the surgical method of the "keyhole" approach to the 
cerebellopontine angle and to find the optimal positioning of the patient so as to prevent some 
complications due to the positioning.
2. To evaluate the relation between three facial pain groups (typical TN, TN with non- 
neuralgic interparoxysmal pain (TNWIP) and persistent idiopathic facial pain (PIFP)) and the 
magnetic resonance angiography (MRA) findings.
3. To assess the value of MRA as indicated by the clinical symptoms and surgical 
findings.
4. To judge the correlation between the clinical symptoms, the type of vascular 
compression and the outcome of MVD.
5. To evaluate the surgical and neurological complications following MVD, and the 
measures to prevent them.
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111. Patients and methods
III. 1. Clinical symptoms of the patients
Three dimensional time of flight (3D TOF) MRA was performed in 310 patients with 
typical TN (214 cases, 69%), TNWIP (65 cases, 21%) or PIFP (31 cases, 10%). Symptomatic 
TN cases where a causative lesion other than NC (e.g. a tumor, an arteriovenous 
malformation, multiple sclerosis, etc.) had been demonstrated by special investigations (CT 
and MRI) were excluded. The three clinical groups were created in accordance with the 
International Classification of Headache Disorders. The “classical TN” group was divided 
into two subgroups. The third group involved PIFP, previously known as atypical facial pain. 
The characteristics of the three clinical groups are as follows (35):
1. Typical TN: Paroxysmal attacks of pain lasting from a fraction of a second to 2 
minutes, affecting one or more divisions of the trigeminal nerve. The pain is 
intense, sharp, superficial or stabbing and/or precipitated from trigger areas or by 
trigger factors. Attacks are stereotyped in the individual patients. There is no 
clinically evident neurology deficit. TN is not attributed to another disorder. The 
pain never crosses to the opposite side, but it may rarely occur bilaterally. 
Following a painful paroxysm, there is usually a refractory period during which 
pain cannot be triggered. The TN is usually responsive, at least initially, to 
pharmacotherapy.
2. TNWIP (also known as atypical TN): the same as above, but there is a dull 
background pain.
3. PIFP: pain in the face, present daily and persisting for all or most of the day. The 
pain is confined at onset to a limited area on one side of the face, and is deep and 
poorly localized. The pain is not associated with sensory loss or other physical 
signs.
III. 2. Imaging techniques
The 3 D TOF MRA investigations were made on two different MR units: a 0.5-Tesla 
(T) Elscint Gyrex VDlx and a 1-T Signa Horizon LX. On the 0.5-T equipment, the 
examination data were: echo time: 9 msec, repetition time: 33-38 msec, flip angle: 25 degrees, 
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slice thickness: 1-1.5 mm, volume thickness: 30-50 mm. Maximum-intensity projections 
(MIP) in 3 standard planes (coronal, sagittal and axial) were focused on the nerve root entry 
zone of both trigeminal nerves. The thin-slice (1 voxel thick) reconstructed images were used 
to clarify the fine anatomical relationship of the nerve and the vessels (81, 81). On the 1-T 
equipment, the following parameters were used: echo time: minimal, repetition time: 33 msec, 
flip angle: 20 degrees, slice thickness: 1 mm, volume thickness: 70 mm. In postprocessing 
procedures, MIP, volume rendering and (sometimes) virtual endoscopy were carried out. All 
measurements were repeated (on both the 0.5-T and the 1-T equipment) after the intravenous 
administration of gadolinium (0.1 mmol/kg) to visualize the veins. The 3 D TOF MRA 
performed without contrast material visualizes the arteries, while with contrast material the 
veins can also be seen. In a further method, the anatomical situation can be assessed on the 
thick slices during postprocessing and arteries can be distinguished from veins according to 
their course (Figure 3).
Figure 3
MR-angioraphy
Left-sided trigeminal neuralgia caused by lower branch of superior cerebellar artery. A: MIP 
reconstruction. B: External virtual endoscopy.
Star: pons, black arrow: superior cerebellar artery; white arrow: trigeminal nerve.
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C: Bilateral vascular compression of the trigeminal nerves (white arrows). The right sided was 
asymptomatic in spite of significant compression by the basilar artery (thick black arrow) 
while the left sided (D) superior cerebellar artery (black arrow) caused typical trigeminal 
neuralgia.
Neurovascular compression (NC) was predicted if distortion (either longitudinal 
bending or cross-sectional deformation or both) of a nerve, caused by a vessel, was observed 
in the 3 D TOF MRA images, or there was no visible gap between the trigeminal nerve and 
the vessel (close contact). The whole cisternal part of the trigeminal nerve was evaluated. NC 
was diagnosed if these findings were detected in either the source images or the reconstructed 
images (15, 61, 48, 79, 81, 82).
In this study, 172 patients were investigated with the 0.5-T MR unit, and 115 patients 
with the 1-T MR unit.
III. 3. Surgical considerations
III. 3.1. Indications for operation
MVD was considered only in those cases where NC was detected in the MRA images 
in accordance with the symptoms, and the medical treatment failed. Patients were usually 
treated with carbamazepine up to 1000 mg daily or with clonazepam up to 8 mg daily, and 
recently with gabapentin up to 1800 mg daily as basic treatment. If the monotherapy was not 
satisfactory, phenytoin up to 300 mg daily and/or Baclofen up to 30 mg daily was given. 
Carbamazepine may cause hematosuppression, hepatic dysfunction, significant lethargy and 
other undesirable side effects. When this pharmacotherapy was not sufficient to control the 
paroxysms or there was some side-effect or intolerance of the treatment (even at a low dose), 
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it was classified as failed medical treatment. In a few cases, the patients refused to take any 
medication (usually because of lethargy) or after a few weeks tired of taking tablets regularly 
and asked for surgical treatment. MVD was offered if the patient was judged to be suitable for 
general anesthesia and accepted posterior cranial fossa exploration.
All patients who met the criteria were enrolled in the surgical study between January 
1994 and December 2004. MVD was performed in 116 cases in 114 patients (2 patients had 
bilateral TN and MVD). From the MRA-negative group, 6 patients who had previously been 
treated several times by glycerol rhizotomy, but in whom the period up to the recurrent pain 
became progressively shorter, were operated on by selective trigeminal rhizotomy.
III. 3.2. Operative technique
III. 3.2.1. Positioning of the patient
After the induction of general anesthesia, the patient is placed in a supine position with 
the head and chest elevated so that the brain is above the level of the heart to minimize the 
cerebral venous pressure. The ipsilateral shoulder is propped up and the head, which is fixed 
in a three-point fixation headrest (Mayfield clamp), is bent forward, laterally inclined, and 
turned to the other side (27). If this angle is not satisfactory for the approach, the patient is 
propped laterally and the whole table is tilted to the contralateral side. At the beginning of the 
performance of MVD, the lateral decubitus (park bench) and prone positions were also used.
IK. 3.2.2. Incision and craniectomy
A paramedian retromastoid incision of about 6-8 cm is made, and the galea and 
periosteum are elevated separately. Soft tissues are retracted with a self-retaining angulated 
retractor. A burr hole is made in the retromastoid area, and the craniectomy is then completed 
with bone nibbiers and/or a high-speed drill. The craniectomy must be situated in the comer 
of the lateral and sigmoid sinus. If mastoid air cells extend behind the sigmoid sinus and 
during craniotomy they are entered, they are packed with muscle and bone wax. A 1.5x2 cm 
craniectomy is usually enough for the approach (Figure 4). The size of craniectomy is small 
enough to be well-protected by the overlying muscles and skin postoperatively, that is why 
craniotomy is not necessary to be performed.
14
Figure 4
Retromastoid keyhole craniectomy in the comer of the lateral and sigmoid sinus
III. 3.2.3. Dural opening and exposure
The dura can be opened parallel to the sinuses or in a Y shape (Figure 4) and stitched 
out. The cerebellar hemisphere is then carefully retracted and cerebrospinal fluid (CSF) can 
be discharged. First the auditory and facial nerves are identified. The arachnoid cistem is 
opened rostral to them. Sometimes the superior petrosal vein covers the nerve; it can be 
coagulated and cut if necessary since the venous network around the brainstem provides a 
good collateral circulation.
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III. 3.2. 4. Microvascuiar decompression
The arachnoid over the trigeminal nerve is opened widely. The nerve has to be 
overviewed from the root entry zone to the petrous bone. Vascular compression has to be 
looked for according to the result of MRA and, additionally, every other compression counts 
and has to be treated. Dissection of all arachnoid is required around the trigeminal nerve and 
the compressing vessel. The most common vessel found is a rostroventral superior cerebellar 
artery (SCA) loop, which compresses the trigeminal nerve either at the brainstem or distally. 
After the arachnoid is dissected and the vessel is freed, the loop can be mobilized from the 
nerve and a piece of gelfoam, shredded Teflon felt, or artificial vessel implant can be placed 
between the vessel and the nerve (Figure 5). The gelfoam is an absorbable material which 
keeps the distance while it absorbs but by this time, arachnoid bundles would preserve the 
"new" anatomical situation. When a stiff vessel causes the NC, and it can hardly be 
mobilized, a piece of Teflon felt or artificial vessel implant is preferable because these 
materials are not absorbable, keep the distance between the nerve and the vessel, and absorb 
the pulsation of the arteries. When a vein is the compressing vessel, it can be separated from 
the nerve and an implant can be placed between the vein and nerve or can be coagulated, 
divided and peeled away from the nerve.
III. 3.2. 5. Closure
At the end of the decompression procedure, several Valsalva maneuvers are performed 
to ensure hemostasis. It is strongly advised to perform a watertight dural closure to prevent 
CSF leakage. The bone edges are carefully waxed and mastoid cells are plugged with muscle 
pieces. The dura is covered with oxidized cellulose and/or gelfoam, and the wound is then 
closed in layers.
III. 3.3. Postoperative treatment
Postoperative care includes observation for around 24 hours in the intensive care unit. 
It is important to monitor the blood pressure and to treat hypertension. Antiemetic medication 
and intravenous fluids are administered to minimize the nausea and emesis. Early 
mobilization is encouraged usually on the second postoperative day. If the postoperative 
course is uneventful, patients are discharged from hospital when they have recovered from the 
headache and nausea, which is generally on the fifth or sixth day.
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Figure 5
Operative photos showing the decompression of the trigeminal nerve under operative 
microscope. After the identification of the structures (1/A, 2/A), the artery is mobilized from 
the trigeminal nerve (1/B, 2/B) and a small piece of spongostan is placed between the 
structures (1/C, 2/C). Abbreviations: nV: trigeminal nerve, nVII: facial nerve, P: pons, SC A: 
superior cerebellar artery, SPV: superior petrosal vein, SP: spongostan
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III. 4. Data collection and evaluation
III. 4.1. Patients' follow up and outcome
The clinical symptoms, MRA findings and surgical observations were recorded. The 
surgical outcome was assessed 1 week, 6 months, and 1, 2, 4, 6, 8 and 10 years 
postoperatively. Patients were encouraged to present for a clinical follow-up at any time when 
they felt any deterioration. The first two follow-ups were clinical, whereas the later ones 
involved letter questionnaires. The outcome regarding the neuralgiform facial pain was 
graded into 6 groups:
1. without pain
2. almost without pain
3. significantly less pain
4. moderately less pain
5. no change
6. worse
The patients additionally had to respond to questions concerning whether they took 
any medication and whether they would suggest MVD to relatives or friends if they had TN.
The classification of the results is as shown in the Table 2.
The recurrence was classified as moderate, which corresponds to the criteria of a good 
outcome, or as severe, which corresponds to the criteria of a poor outcome.
For the purposes of the analysis, patients who underwent bilateral MVD were counted 
twice (once for each side).
III. 4.2. Statistics
The results were analyzed by chi-square tests, using SPSS 11.0 software (SPSS Inc., 
Chicago, IL). In the cases of 2X2 crosstabs, Fischer's exact test (2-sided) was applied. For the 
analysis of successful outcomes, Kaplan-Meier analysis was performed. Differences were 
considered statistically significant when p<0.05.
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Table 2
Outcome measures
Outcome Postoperative pain Additional treatment
Excellent Without
Almost without
None
Good Without
Almost without
Intermittent low-dose medication
Significantly less 
Moderately less
None/Intermittent low-dose medication
Poor Without
Almost without 
Significantly less 
Moderately less
High-dose medication
No change 
Worse
High-dose medication/Additional surgical 
treatment
Low-dose medication: 400-800 mg carbamazepine daily
High-dose medication: >800 mg carbamazepine daily or/and combination therapy
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IV. Results
IV. 1. Clinical symptoms and 3D TOF MRA images
From among the 310 patients with facial pain who underwent 3 D TOF MRA, the 
result was positive in 179 cases (58%) and negative in 131 cases (42%). In the MRA-positive 
group, there were 146 typical TN cases, 32 TNWIP cases and 1 PIFP case. In the TN group 
(both typical TN and TNWIP), there were positive MRA results on the asymptomatic side in 
30 cases (10.7%). The distribution of the MRA results with respect to the clinical symptoms 
revealed a significantly higher positive rate in the typical TN group than in the TNWIP group 
(68.2% vs. 49.2%, p<0.01). In the PIFP group, there was only 1 (3.2%) MRA-positive case 
(Table 3).
Table 3
Distribution of the MRA results in the three clinical groups
MRA-positive MRA-negative
Typical TN n = 214 (100%)
TNWIP n = 65(100%)
PIFP n= 31(100%)
146 (68.2%)
32 (49.2%) 
1 (3.2%)
68 (31.7%)
33 (50.7%)
30 (96.7%)
There was a great difference between the proportions of the MRA-positive and 
negative cases, depending on which MR unit was used in the diagnostic procedure (Table 4).
Table 4
Sensitivities of the different MR units in the three clinical groups
0.5-T MR unit 1-T MR unit
Positive Negative Positive Negative
Typical TN 86 (59%) 60 (41%) 60 (88%) 8 (12%)
TNWIP 4 (25%) 12 (75%) 28 (57%) 21 (43%)
PIFP 0 10(100%) 1 (4.7%) 20 (95.2%)
The types of NC seen on MRA in the three clinical groups are listed in Table 5. In the 
typical TN group, the rate of arterial compression was much higher (90.4%) than that in the 
TNWIP group (50%), whereas venous compression was seen more frequently in the TNWIP 
group (25%) than in the typical TN group (0.7%) (p<0.001).
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Types of NC seen on MRA in the clinical groups
Table 5
Type of NC Typical TN 
n=146 (100%)
TNWIP 
n=32 (100%)
PIFP 
n=l
Arterial n=149 132 (90,4%) 16(50%) -
Mixed n=20 12(8.2%) 8 (25%) -
Venous n=10 1 (0.7%) 8 (25%) 1
IV.2.  Comparison of 3D TOF MRA images and intraoperative observations
Between January 1994 and December 2004, 112 patients underwent unilateral MVD 
and 2 patients underwent bilateral MVD. The general characteristics of the patients are 
presented in Table 6.
In the 114 patients and 116 cases, we could always identify NC on MRA (which was 
mandatory for the MVD in this series). The 0.5-T MR unit was used in 56 cases, and the 1-T 
MR unit was used in 47 cases to demonstrate the NC. During surgery, NC was observed in 
110 cases (95%), while in 6 cases (5%) we could find a loose contact, when an artery was 
running on the nerve, but there was no distortion of the nerve, or there was a visible gap 
between the nerve and the artery and the vessel touched the nerve periodically, only in the 
systolic phase. This loose contact could be seen in 3 cases in the group where the 0.5-T unit 
was used, and also in 3 cases where the 1-T MR unit was used.
When the 0.5-T MR unit was used, in 3 cases the NC seemed to be arterial on MRA, 
but proved venous during surgery. Re-evaluation of the MRA scans of these patients 
postoperatively led to the identification of veins instead of the superior cerebellar artery. (This 
was the fault of the initial evaluation, but not of the method.) In the remaining 113 cases 
(97.4%), the MRA findings corresponded to the surgical observations. In 109 (94%) cases, 
the compression was arterial (99 pure arterial, and 10 mixed arterial+venous); only in 7 cases 
(6%) was pure venous compression found (Table 7).
In the 6 patients operated on from the MRA-negative group (3 patients were 
investigated with the 0.5-T and 3 with the 1-T MR unit) in whom open craniotomy was 
carried out for selective rhizotomy, no NC of the trigeminal nerves was observed during 
surgery.
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Table 6
General characteristics of the 114 operated patients
Characteristic Value
Age at surgery - yr
Median 59.3
Range 24-85
Sex
Male 58
Female 56
Site of operation - no. (%)
Left 49(43)
Right 63 (55)
Bilateral 2(2)
Age at onset of symptoms - yr
Median (range)
All cases 52 (14-78)
In cases of typical TN 54 (14-78)
In cases of TNWIP 42 (23-68)
Preoperative duration of symptoms - yr
Median 8
Range <1-40
Prior drug treatment - no. (%)
Carbamazepine 116(100)
Phenytoin 41 (35)
Baclofen 12(10)
Prior ablative treatment - no. (%)
Any procedure 42 (36)
Glycerol rhizotomy 29 (25)
Radiofrequency Gasserian lesion 8(7)
Peripheral nerve procedures 10(9)
Other 7(6)
Distribution of pain - no. (%)
V/1 only 9(8)
V/2 only 33 (28)
V/3 only 16(14)
V/1-2 19(16)
V/2-3 35 (30)
V/1-2-3 4(3)
Preoperative facial numbness - no. (%)
Hypesthesia, hypalgesia 28 (24)
Symptoms - no. (%)
Typical TN 98(84)
TNWIP 17(15)
PIFP 1 (1)
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Vessels causing NC (surgical observations, n=l16)
Table 7
Name of the vessel No.
Superior cerebellar artery 84
Anterior inferior cerebellar artery 10
Basilar artery 2
Vertebral artery 1
Superior+anterior inferior cerebellar arteries 1
Basilar+anterior inferior cerebellar arteries 1
Superior cerebellar artery+vein 10
Vein 7
As concerns the surgical findings, the rate of arterial NC was significantly higher in 
the typical TN group (91.8%) than in the TNWIP group (53%). Pure venous compression was 
found frequently (29.4%) in the TNWIP group, whereas it was rare (1%) in the typical TN 
group (p<0.0001) (Table 8).
Table 8
Type of NC in respect of the clinical symptoms (surgical findings)
Type ofNC Typical TN 
n=98 (100 %)
TNWIP 
n=17 (100 %)
PIFP 
n=l
Arterial n=99 90 (91.8%) 42 - 48* 9 (53%) 4-5* -
Mixed n=9 7(7.1%) 5-2* 3(17.6%) 1-2* -
Venous n=7 1 (1.2%) 1 -0* 5 (29.4%) 3-2* 1 0-1*
* Distribution of cases according to the type of MR units (0.5-T or 1-T, respectively) used to 
demonstrate the NC.
IV3. Outcome after microvascular decompression
The median length of follow-up for the 114 patients (116 cases) was 40.3 months. One 
patient died from cardiac failure 3 weeks postoperatively; 7 other patients (6.1 %) were lost to 
follow-up, 1 after 1 year, 4 after 2 years, and 2 after 4 years.
The immediate postoperative relief from neuralgiform pain was complete in 91%, 
partial in 4% and absent in 4%. Six months after MVD, 89% gave excellent, 5% good and 5% 
poor results. One year after MVD, 82% gave excellent, 11% good and 7% poor results. Two 
years postoperatively, 74% gave an excellent, 18% a good and 8% a poor result. Four years
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after the procedure, 69% of the patients gave excellent, 23% good and 7% poor results (Table 
9, Figure 6).
Table 9
Distribution of outcome after given follow-up periods
Excellent Good Poor No. of pts.
1 week 106(91%) 5 (4%) 5 (4%) 116
6 months 103 (89%) 6 (5%) 6 (5%) 115
1 year 90 (82%) 12(11%) 8 (7%) 110--—£_________ _
2 years 74 (74%) 18(18%) 8 (8%) 100
4 years 46 (69%) 15 (23%) 5 (8%) 66
6 years 20 (67%) 6 (20%) 4 (13%) 30
8 years 8 (57%) 3(21%) 3 (21%) 14
10 years 1 0 1 2
Figure 6
Kaplan-Meier analysis of the success of MVD. The curves show the proportions 
of patients with successful outcomes after MVD.
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Most of the recurrences, either severe or moderate, appeared within 2 years following 
MVD. In only 2 cases did the recurrent neuralgiform pain appear 4 and 6 years following 
MVD (Table 10).
Table 10
Time of onset of recurrence and its severity
Immediate 6 months 1 year 2 years 4 years 6 years
Severe 
recurrence 5 2 1 - - 1
Moderate 
recurrence 5 2 7 5 1 -
One patient, who experienced a moderate recurrence 6 months after MVD, suffered a 
severe recurrence 1 year later. Altogether 30 patients had some kind of recurrence. From 
among the 9 severe recurrent cases, 2 patients had repeated MRA, one of them revealed 
recurrent NC, and the MVD was repeated, in the other case the repeated MRA showed no 
NC. One patient was treated with selective rhizotomy, 1 with stereotactic thalamotomy, and 3 
with glycerol rhizotomy; the remaining recurrent cases resumed taking medication.
The distribution of the compressing vessels in the cases in which recurrence appeared 
is to be seen in Table 11.
Table 11
Compressing vessels in recurrent cases
Severe recurrence (no.) Moderate recurrence (no.)
Superior cerebellar artery 4 16
Basilar artery 1 2
Anterior inferior cerebellar artery 1
Superior cerebellar artery 1
Vein 2 2
While the rate of some kind of recurrence among the typical TN cases was only 
21.4%, among the TNWIP cases it was 41.1% (approaching significance, p=0.054) (Table 
12).
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Table 12
Onset of recurrence in the different clinical symptoms in the all patients
Typical TN 
(n=98,100%)
TNWIP (n=17, 
100%)
PIFP 
(n=l)
Severe recurrence 5(5.1%) 3(17.6%) 1
Moderate recurrence 16(16.3%) 4 (23.5%)
AU 21 (21.4%) 7(41.1%) 1
Four years after at the MVD, the rate of some kind of recurrence was 23.2% in typical 
TN group, while it was 60% in the atypical TN group (Table 13).
Table 13
Recurrences in the two TN groups four years after the MVD
Typical TN 
(n=56,100%)
TNWIP 
(n=10,100%)
Severe recurrence 2 (3.6%) 3 (30%)
Moderate recurrence 11 (19.6%) 3 (30%)
All 13 (23.2%) 6 (60%)
IV. 4. Postoperative complications
Complications were analyzed as cranial nerve deficits or other surgical consequences 
(Tables 14/A and 14/B). There was no mortality, posterior fossa hematoma or anesthesia 
dolorosa. Altogether 30 patients (26%) suffered some kind of complications, 3 of them 2 
complications. Tbe transient neurological deficits disappeared with time and the surgical 
complications could be treated; therefore for a long time only the permanent cranial nerve 
deficits (12%) caused problems for the patients. The most serious permanent complication 
was the keratitis due to the sensory loss of the first branch of the trigeminal nerve.
CSF leakage could be treated with lumbar CSF drainage in 5 cases, while in 1 case the 
wound had to be opened and duraplasty was performed. There were 2 wound infections, 
which needed a complete wound revision and re-suturing. Due to the retraction of the 
cerebellum, cerebellar edema and hydrocephalus developed in 1 patient. This required the 
ventricular drainage of CSF until the patient had recovered.
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Table 14/A
Neurological complications (cranial nerve deficits) of MVD
Complications Transient Permanent
Sensory loss/paresthesia 2 7
Keratitis - 1
Facial palsy 1 -
Hypacusis, tinnitus 4 6
Table 14/B
Surgical complications of MVD
Complications No. Treatment Result
CSF leakage 6 lumbar drainage (5), duraplasty (1) cured
Wound infection 2 wound revision cured
Cerebellar edema, hydrocephalus 1 ventricular drainage cured
IV. 5. The patients’ assessments of MVD
Five of the patients would not recommend MVD in the future. All of them belonged in 
the group who complained of immediate recurrence of the pain. Three patients did not answer 
this question. All three gave a poor final result. One patient died 3 weeks after MVD. One 
patient, who underwent MVD on both sides, with an excellent result on one side, but a poor 
result on the other side, both recommended and did not recommend MVD. All the other 105 
patients (90%) recommended MVD for TN.
T1
V. Discussion
V. 1. The keyhole approach and positioning of patients for surgery
The lateral suboccipital approach to the cerebellopontine angle for the purpose of 
reaching the fifth nerve has been a well-known procedure since 1932 (23). In the 1960s, when 
the operative microscope started to be used routinely, there was the possibility to decrease the 
size of the craniotomy and incision. At the beginning of the learning process of the surgical 
technique, we also used to perform a 10-12 cm long skin incision and a lateral suboccipital 
craniotomy 3-4 cm in diameter. When we had acquired practice in performing the MVD, the 
skin incision became 6-7 cm long and the craniotomy approximately 2 cm in diameter. The 
exact positioning of the craniotomy in the angle of the lateral and sigmoid sinus is crucial to 
perform the keyhole approach. Even if the patient has large mastoid cells, they have to be 
opened and removed to the edge of the sinus. During the operation, the surgeon has to use 
bayonet instruments so as not to cover the operating field under the microscope.
When the initial series of MVD was performed in our department, patients were 
positioned in the sitting or park bench position. Since there was a severe complication due to 
air embolism in the sitting position, no other patient was operated on for MVD in this 
position. In this series, all 114 patients were operated on in either the prone, the park bench or 
(most of them) in supine position (introduced by P.Barzo). The main advantage of the supine 
position is the low risk of hypotensive circulatory problems and air embolism. A further 
advantage is that no retraction of the cerebellar lobe is necessary to visualize the fifth nerve 
from the entry zone to its entrance in Meckel's cave, for it drops as a result of gravity. In 
patients positioned in the supine position, we had no complications related to the cerebellar 
retraction (cerebellar infarct, loss of hearing or facial palsy). It should also be mentioned that 
the compressed surface of the patient is large on the back and sometimes on one side, and the 
ventilation is not influenced by compression of the chest. This is important for elderly and 
corpulent patients.
The keyhole approach with the patient in the supine position provides a less invasive 
method to perform MVD. The easy mode of patient positioning and the small approach makes 
the conditions safe and favourable, so that the operation is faster than in another position 
and/or with a large approach. The small incision also provides less postoperative pain in the 
operative field.
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V. 2. The relation between three facial pain groups (typical TN, TNW1P and 
PIFP) and the MRA findings. The value of MRA
In most classical TN cases, vascular compression of the trigeminal nerve is involved 
in the etiology, and MVD is a safe surgical method widely used throughout the world for the 
treatment of TN. However, there have been reports that NC can not always be found during 
surgical exploration. These negative findings varied from 0% to 89% with an average 7.5% 
(1,9, 11, 13, 18, 20, 34, 37, 46, 45, 65, 75, 76); the rate in our initial series was 20%. Before 
considering a posterior cranial fossa exploration for MVD, to prove the presence of NC of the 
trigeminal nerve is advisable. MRI and later MRA investigations have demonstrated the 
usefulness of the preoperative evaluation of NC in TN cases (2, 15, 31, 32, 57, 60, 61, 64„ 77, 
81,82, 85).
In everyday clinical practice, neurologists encounter many patients with unilateral 
facial pain that is difficult to classify into the well-known types of headaches, facial pain 
syndromes and TN. In these PIFP cases, the origin of the pain is unclear and the treatment is 
often not fruitful. We performed 3D TOF MRA in 31 patients with PIFP, and only 1 of them 
yielded a positive result. This was most probably only an accidentally positive NC because 
this patient showed no improvement after MVD. On the basis of these results, we can rule out 
NC in the background of PIFP.
The situation with typical TN and TNWIP cases was quite different. The MRA 
findings were positive in 68.2% in the typical TN group, and in 49.2% in the TNWIP group. 
Patients were selected for MVD only from among the MRA-positive cases (98 typical TN, 
and 17 TNWIP), and in all these cases NC was found during surgery. With regard to the good 
postoperative results after MVD in the literature and in the present series, NC appears to be an 
obvious etiological explanation of typical TN and TNWIP. However, it is noteworthy that, 
whereas typical TN was found to be caused by pure venous compression in only 0.7% on 
MRA and in 1% during surgery, TNWIP was caused by pure venous compression in 25% on 
MRA and in 29.4% during surgery. This might seem significant (p<0.01), but the small 
number of our cases permits only the suspicion that venous compression may cause TNWIP. 
On this basis, the different clinical symptoms (typical TN and TNWIP) seem to be dependent 
on the type of the compressing vessel. The duration of compression may also influence the 
appearance of clinical symptoms, and the typical TN form sometimes transforms into the 
TNWIP form (19).
It should be stressed that only patients who gave positive imaging results for NC were 
included in the MVD-treated group. It may be supposed that more cases from the MRA-
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negative group had NC, but the vessels were too small to be detected. The quality of the MR 
unit seems to be very important in this process. In our series of patients with TN, there were 
72 patients with negative MRA results on use of the 0.5-T machine. The relative data suggest 
that, of these cases, 31 would have been positive if the 1-T MR unit had been used (see Table 
15). This was not available to us at that time, but it means that approximately 31 patients were 
denied MVD due to “poor” MRA.
Table 15
The proportion of MRA positive and negative TN cases on the different MR units
0.5-T MR unit * 1-T MR unit
MRA-positive cases - no. (%) 90(55) 121(75) 88(75)
MRA-negative cases - no. (%) 72 (45) 41(25) 29 (25)
All cases - no. (%) 162(100) 162(100) 117(100)
* probable numbers if the 1-T MR unit had been used in the cases investigated with the 0.5-T 
MR unit
When the MRA investigations were performed with the 0.5-T machine, the positive 
ratio in the typical TN group was 60% (81); the corresponding value with the 1-T machine 
was 88%. This latter positive ratio approaches that for the surgically positive cases of Jannetta 
(39), and some cause other than NC (probably of central origin (14, 42, 43)) in the 
background of typical TN can be suspected in only 12%. At this point, the question arises of 
whether it is worth performing MRA in patients with typical TN when the expected negative 
ratio is only 12%. The answer may be "no" if we consider selective partial rhizotomy as an 
alternative to MVD, while it may be "yes" if we consider other surgical treatment (glycerol 
rhizotomy, thermocoagulation, balloon compression, etc.).
In the TNWIP group, the positive MRA ratio was 25% with the 0.5-T machine, and 
57% with the 1-T machine (Table 4). In this clinical group, preoperative MRA investigation 
seems to be indicated unequivocally. The previous published MRA studies were performed 
on 1.5-T MR machines (2, 15, 60, 61, 64, 85). Even with such technically superior 
equipments, there were false-negative cases (15, 31, 61, 64), which indicates that small 
arteries and also veins and thickened arachnoids can probably go undetected on MRA. 
Unfortunately, there are no data regarding the type of TN in these cases.
30
The 10.4% NC on the asymptomatic side suggests that the clinical symptoms and 
MRA results must be evaluated together. If we consider the same proportion of asymptomatic 
NC on the symptomatic side, this may explain the unsuccessful MVDs, where causes other 
than NC were to be found in the background of TN.
There were 6 operative cases where only loose contact could be observed during 
surgery; however, an NC was obvious on MRA. This reflects the importance of the condition 
of the patients. The position of the head and the discharge of CSF during surgery may modify 
the relationship of the nerve and vessel (34, 39). It is worthwhile to mention that all 6 patients 
had typical TN, and 5 of them exhibited an excellent and 1 of them a good outcome.
V. 3. Correlation between clinical symptoms, type of vascular compression and 
outcome of MVD
Many factors which may contribute to the success of MVD have been discussed in the 
literature, in connection with large series of TN patients (9-11, 13, 18, 20, 21, 45, 46, 62, 65, 
67, 75, 76, 78). This study focused on the clinical symptoms and type of vascular 
compression. Szapiro et al. (76) consider the mode of pain manifestation of TN to be the most 
significant prognostic factor in the outcome of MVD. They categorize "paroxysmal pain only" 
and "paroxysmal with a permanent pain component". These two clinical groups correspond to 
our typical TN and TNWIP groups. Szapiro et al. (76) found that 95% of the typical TN group 
and 58% of the atypical TN group could be cured. Tyler-Karaba et al.(78) found these 
numbers to be 73% and 35% respectively.
In this study, 78.6% of the typical TN group were considered cured, while 16.3% had 
a moderate and 5.1% a severe recurrence; in the TNWIP group, 58.9% were cured, while 
23.5% had a moderate and 17.6% a severe recurrence (Table 12). Four years after the MVD 
76.8% of the typical TN patients seemed to be cured, while 19.6% had a moderate and 3.6% 
severe recurrence, while in the TNWIP only 40% was cured, 30% had moderate and severe 
recurrence (Table 13). Patients with TN treated by ablative neurosurgical techniques also 
seemed to have a better outcome if they had typical TN rather than TNWIP (55, 56, 66, 86). 
With respect to these results, we may say that the clinical appearance of the TN is an 
important prognostic factor in the outcome of MVD, and taking an exact history from the 
patient is mandatory.
The personality of the patient can also influence the outcome. Usually the depressed 
personality patients belong to the PIFP group, but sometimes, patients with longstanding TN 
get depressed and after the MVD the evaluation of the result can be misleading as the patient 
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can not appreciate the improvement. There was 1 patient in the severe recurrence group with 
TNWIP who mentioned no neuralgiform pain after MVD but claimed no change probable due 
to severe depression.
With regard to the special vessels and the number of all recurrences, it can be seen 
that, in the cases where the basilar artery and veins are involved in the NC, the probability of 
recurrence is higher than in the other cases (Table 16). The reason for the recurrences in the 
basilar artery-caused NC cases might be the stiffness of the artery, which could therefore be 
mobilized away from the nerve only with difficulty (52). Since we used gelatin foam 
interposition between the nerve and vessel, the stiffness of the vessel may compress the 
gelatin foam after a certain time, the newly formed arachnoid bundles are not strong enough 
to keep the distance between the nerve and vessel and the NC can be reappeared. This may be 
the cause of the recurrence of the other arterial compressions. The superior cerebellar artery 
and the anterior inferior cerebellar artery are also sometimes very stiff and difficult to move.
Table 16
Number of special compressing vessels and proportions of recurrences
Type of vessel
Number of NC 
(aU=116)
Number of 
recurrences (%) 
(all=29)
Superior cerebellar artery 84 20 (23.8)
Basilar artery 2 2(100)
Basilar+anterior inferior cerebellar arteries 1 1 (100)
Anterior inferior cerebellar artery 10 1(10)
Superior cerebellar artery+vein --------- 10 1(10)
Pure vein 7 4(57)
Superior+anterior inferior cerebellar arteries 1 0
Vertebral artery 1 0
In 1 patient having typical TN, the sensory root of the trigeminal nerve was divided 
longitudinally by a superior cerebellar artery loop; the distance between the two parts of the 
nerve (where the loop was) was around 10 mm, and the nerve seemed to be completely 
degenerated. In this case, there was no clinical improvement at all after MVD and later 
elective rhizotomy. It is presumed that the TN originated from the central structures by the
time of MVD; nevertheless, the arterial compression could originally have been involved in
the etiology (13,30).
The reason for the recurrences in cases involving the veins might be different. In most 
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cases, the compressing veins were divided and no chance of NC remained following MVD. In 
spite of this, venous compression predicts a higher rate of recurrence of TN (11, 18, 21, 34, 
45, 75). Since veins can be distinguished from arteries on MRA, the positive MRA result may 
play a predicting role in the prognosis following MVD.
Considering the causes of the immediate failure of MVD (5 cases), there are no 
common characteristics of these cases. One patient with the divided and degenerated 
trigeminal nerve is described above. The 2nd patient had typical TN caused by the anterior 
inferior cerebellar artery. The 3rd patient was the severely depressed one with TNWIP caused 
by the superior cerebellar artery. The 4th patient is the one of the bilateral TN cases, had 
TNWIP with a NC caused by the superior cerebellar artery. The 5,h patient was the one with 
PIFP. In the 2nd and 4th cases, TN of central origin was presumed and NC was only accidental 
finding. Other possibility of the failure could be the aberrant remyelination in the entry zone 
of the trigeminal nerve by the time of MVD. In the 3rd case the neuralgiform pain 
discontinued but due to the depression and the basic pain the patient had not appreciated the 
improvement. In the 5th patient with the PIFP the venous NC was only accidental finding.
V. 4. Complications following MVD
A literature review (20) reveals a mortality rate of 0.5%, the risk of posterior fossa 
hematoma or infarction being 0.3% and 0.1% respectively. In this series, there were no such 
complications. The relative occurrence of other types of complications in the literature and in 
this series is compared in Table 17.
Table 17
Comparison of rates of complications in the literature and this series
Complication CSF leak Cranial nerve deficit
5th 7th 8th
Literature 1.2% 1.5% 0.3% 1.9%
This series 5.1% 6.9% 0 5.1%
It is obvious that the rate of complications in this series is significantly higher than in 
the literature. One of the reasons for this might be that the series in the literature contains 
hundreds of patient operated on by one surgeon. It is not surprising that, with increasing 
experience, the complication rate falls and the rate of a successful outcome rises (47). In this 
series, patients were operated on by 6 surgeons, only 3 with appropriate experience, and in the 
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initial cases there were many more complications than in the subsequent ones (inexperienced 
surgeons have got only initial cases).
The deficits of cranial nerves are the consequences of either the traumatization of the 
nerves during the separation from the vessel or the excessive retraction of the cerebellum. The 
latter was the cause of the cerebellar edema as well. It is not clear, why were there 6 
permanent hypacusis/tinnitus complications, while there was no permanent facial palsy. Is the 
cochlear nerve more sensitive than the facial nerve? With a careful surgical technique, 
almost all the complications can be avoided (Table 18). The possibility of intraoperative 
monitoring of brainstem-evoked response was not available, but, since the keyhole approach 
has been used with the supine positioning of the patient and the cerebellar retraction has not 
been applied, there have been no permanent 7th or 8th nerve deficits.
Table 18
Surgical techniques to prevent complications following MVD
Complication Prevention
7th and 8th nerve deficits intraoperative monitoring of brainstem-evoked response, keyhole approach, supine position
5th nerve deficit careful dissection of the nerve from the vessel
cerebellar edema, infarct keyhole approach, supine position,
CSF leakage careful closure of the dura and mastoid cells
V. 5. Questions to be answered in the future
Not too much known is about the potential different effects of arterial versus venous 
compression and the possible influence on the outcome of MVD. We may merely 
hypothesize, but without experimental or pathological proof. Arterial compression has two 
components: the constant compression due to the anatomical position of the vessel and the 
strong rhythmic pulsation force on the nerve. Venous compression has only a constant 
“positional” compressing force, but no strong pulsation. Both types of compression can cause 
focal demyelination, but there might be some difference between them. This pathological 
difference might be subtle, because both arterial and venous compression can cause typical 
TN and TNWIP, whereas arterial compression causes mainly typical TN, while in TNWIP 
venous compression can frequently be found. An animal model or intraoperative biopsy taken 
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from the affected nerve or sample from the trigeminal nerve of cadavers who had previously 
had TN may settle this hypothesis, but these seems to be rather difficult in practice (24,73). 
The pathomechanism must be clarified in the future.
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VI. Conclusions (according to the aims of this study)
1. The surgical technique described by Jannetta could be learned and performed. The 
keyhole approach together with the supine positioning of the patient provides a safe 
approach to the trigeminal nerve in the pontocerebellar cistern.
2. MRA findings were different in the three facial pain groups:
• PIFP is not related to NC of the trigeminal nerve.
• NC can be identified on MRA on a 1-T MR device in 88% of the typical TN 
cases and 57% of the TNWIP cases.
• TNWIP is caused by venous compression at a significantly higher rate than 
that for typical TN.
3. MRA can be involved in the decision-making when considering MVD.
• The type of MR unit significantly determines the accuracy of the MRA result 
and the percentage of MRA-positive cases. At least a 1-T MR unit is needed 
for the investigations.
• Arterial and venous compression can be differentiated.
• MRA-negative cases, and especially TNWIP cases, can be considered for 
treatment other than MVD.
4. The clinical symptoms, the type of NC and the outcome of MVD are related:
• Typical TN cases can be cured by MVD at a higher rate (-80%) than can 
TNWIP cases (—60%). This may be the most important prognostic factor in 
MVD (38).
• The type of NC may play a role in the recurrence of TN following MVD.
• The presence of venous compression is a sign of a poor prognosis (11,18 21 
34,45, 75).
• In TNWIP, venous compression is more frequent than in typical TN.
5. The keyhole technique and the good positioning of the patient for MVD may prevent 
edema of the cerebellar lobe and cranial nerve deficit complications; the experience of 
the surgeon plays a significant role in the prevention of complications and in the 
success of MVD.
VII. New results in this study
1. The author has reported the first series of TN cases treated with MVD in Hungary.
2. The largest number of patients with TN and PIFP were investigated with three 
dimensional MRA. The findings were evaluated according to the clinical symptoms.
3. The prognostic value of the MRA regarding to the post MVD result was determined 
by comparison of MRA and the surgical findings.
4. PIFP is ruled out as a NC of the trigeminal nerve.
5. In TNWIP, the venous compression is more frequent than in typical TN.
6. At least a 1-T MR unit is necessary for the investigations to reveal NC properly.
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